Physician profile
Trushil Patel
NPI 1295268068
$5,304.53
in general payments reported to CMS, 2019-2025
16 companies · $215 in 2025
The $215 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $60.59 · 2021: $919 · 2022: $665 · 2023: $1,182 · 2024: $2,263 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,306 · Travel and Lodging: $1,263 · Education: $91.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,305.93 |
| Travel and Lodging | $1,262.88 |
| Education | $91.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,307.56 | 2020-2025 | Diamondback Coronary, Aveir, Optis |
| Medical Device Business Services, INC. | $1,262.88 | 2024 | Carto 3 |
| Cardiovascular Systems INC. | $723.71 | 2021-2023 | Diamondback Peripheral, Diamondback Coronary |
| Shockwave Medical, INC | $480.78 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $408.79 | 2021-2024 | Watchman Flx |
| Medtronic, INC. | $400.09 | 2021-2024 | Cobalt Dr Mri Surescan, Micra |
| W. L. Gore & Associates, INC. | $258.22 | 2024-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Iliac Branch Endoprosthesis |
| Pfizer INC. | $105.41 | 2022-2025 | |
| Kestra Medical Technology Services, INC. | $99.78 | 2024-2025 | Assure Wcd |
| Biosense Webster, INC. | $95.49 | 2024 | Carto 3 |
| Pacira Pharmaceuticals Incorporated | $37.79 | 2024 | Exparel |
| Medtronic Vascular, INC. | $35.75 | 2020 | |
| Stryker Corporation | $32.80 | 2025 | Flowsaver |
| Lantheus Medical Imaging, INC. | $23.30 | 2023 | Definity |
| Amgen INC. | $19.45 | 2024 | Repatha |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $12.73 | 2023 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trushil Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.